Saved in:
| Main Authors: | Chen, Kai, Zhao, Yixuan, Takeda, Kentaro, Yuan, Ying |
|---|---|
| Format: | Preprint |
| Published: |
2025
|
| Subjects: | |
| Online Access: | https://arxiv.org/abs/2509.11333 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
ROMI: A Randomized Two-Stage Basket Trial Design to Optimize Doses for Multiple Indications
by: Wang, Shuqi, et al.
Published: (2024)
by: Wang, Shuqi, et al.
Published: (2024)
BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
by: Chen, Yuxuan, et al.
Published: (2026)
by: Chen, Yuxuan, et al.
Published: (2026)
BOP2-TE: Bayesian Optimal Phase 2 Design for Jointly Monitoring Efficacy and Toxicity with Application to Dose Optimization
by: Chen, Kai, et al.
Published: (2024)
by: Chen, Kai, et al.
Published: (2024)
Dual-criterion Dose Finding Designs Based on Dose-Limiting Toxicity and Tolerability
by: Yang, Yunlong, et al.
Published: (2024)
by: Yang, Yunlong, et al.
Published: (2024)
Hybrid Non-informative and Informative Prior Model-assisted Designs for Mid-trial Dose Insertion
by: Yamada, Kana, et al.
Published: (2026)
by: Yamada, Kana, et al.
Published: (2026)
ROSE: Randomized Optimal Selection Design for Dose Optimization
by: Wang, Shuqi, et al.
Published: (2025)
by: Wang, Shuqi, et al.
Published: (2025)
BOIN ‐ MEM : A Two‐Stage Design for Dose Optimization With Information Borrowing Across Dose Levels and Stages in Oncology Phase I/ II Trials
by: Ryo Kitabayashi, et al.
Published: (2025)
by: Ryo Kitabayashi, et al.
Published: (2025)
COMIC: A Bayesian Dose Optimization Design for Drug Combination in Multiple Indications With Application to CAR‐T Therapies
by: Kai Chen, et al.
Published: (2025)
by: Kai Chen, et al.
Published: (2025)
Should the choice of BOIN design parameter p.tox only depend on the target DLT rate?
by: Lu, Rong
Published: (2024)
by: Lu, Rong
Published: (2024)
Utility-Based Dose Optimization Approaches for Multiple-Dose Randomized Trial Designs Accounting for Multiple Endpoints
by: DAngelo, Gina, et al.
Published: (2025)
by: DAngelo, Gina, et al.
Published: (2025)
Statistical Operating Characteristics of Current Early Phase Dose Finding Designs with Toxicity and Efficacy in Oncology
by: Sun, Hao, et al.
Published: (2024)
by: Sun, Hao, et al.
Published: (2024)
BARD: A seamless two-stage dose optimization design integrating backfill and adaptive randomization
by: Zhao, Yixuan, et al.
Published: (2024)
by: Zhao, Yixuan, et al.
Published: (2024)
Modifying Survival Models To Accommodate Thresholding Behavior
by: Betancourt, Michael
Published: (2022)
by: Betancourt, Michael
Published: (2022)
A Seamless Phase II/III Design with Dose Optimization for Oncology Drug Development
by: Li, Yuhan, et al.
Published: (2024)
by: Li, Yuhan, et al.
Published: (2024)
Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
by: Lee, Kyong Ju, et al.
Published: (2025)
by: Lee, Kyong Ju, et al.
Published: (2025)
Bayesian Optimization for Identification of Optimal Biological Dose Combinations in Personalized Dose-Finding Trials
by: Willard, James, et al.
Published: (2024)
by: Willard, James, et al.
Published: (2024)
A Likelihood Perspective on Dose-Finding Study Designs in Oncology
by: Zhang, Zhiwei
Published: (2023)
by: Zhang, Zhiwei
Published: (2023)
Prior-Free Sample Size Design for Test-and-Roll Experiments
by: Kawato, Kentaro, et al.
Published: (2026)
by: Kawato, Kentaro, et al.
Published: (2026)
TWICEBEE: A Two-stage Intra-patient Curve-free Bayesian Decision-Theoretic Dose Escalation Design
by: Bi, Dehua, et al.
Published: (2026)
by: Bi, Dehua, et al.
Published: (2026)
Two-dose vs. Three-Dose Optimization Under Sample Size Constraint
by: Sun, Linda, et al.
Published: (2026)
by: Sun, Linda, et al.
Published: (2026)
A Utility Score Framework for Dose Optimization Studies with Binary Efficacy-Safety Endpoints: Sample Size Determination and Bias Characterization
by: Gu, Xuemin, et al.
Published: (2026)
by: Gu, Xuemin, et al.
Published: (2026)
Reclustering: A New Method to Test the Appropriate Level of Clustering
by: Fukumoto, Kentaro
Published: (2025)
by: Fukumoto, Kentaro
Published: (2025)
Scale-Location-Truncated Beta Regression: Expanding Beta Regression to Accommodate 0 and 1
by: Kim, Mingang, et al.
Published: (2025)
by: Kim, Mingang, et al.
Published: (2025)
sfislands: An R Package for Accommodating Islands and Disjoint Zones in Areal Spatial Modelling
by: Horan, Kevin, et al.
Published: (2024)
by: Horan, Kevin, et al.
Published: (2024)
Bayesian Optimization for Personalized Dose-Finding Trials with Combination Therapies
by: Willard, James, et al.
Published: (2023)
by: Willard, James, et al.
Published: (2023)
CUI-MET: Clinical Utility Index Dose Optimization Approach for Multiple-Dose, Multiple-Outcome Randomized Trial Designs
by: Zhang, Fanni, et al.
Published: (2025)
by: Zhang, Fanni, et al.
Published: (2025)
Personalized Two-sided Dose Interval
by: Park, Chan, et al.
Published: (2023)
by: Park, Chan, et al.
Published: (2023)
An Adaptive Phase II Trial Design for Dose Selection and Addition in Microfilarial Infections
by: Zehetmayer, Sonja, et al.
Published: (2026)
by: Zehetmayer, Sonja, et al.
Published: (2026)
LORDs: Locally Optimal Restricted Designs for Phase I/II Dose-Finding Studies
by: Sverdlov, Oleksandr, et al.
Published: (2025)
by: Sverdlov, Oleksandr, et al.
Published: (2025)
Accommodating informative visit times for analysing irregular longitudinal data: a sensitivity analysis approach with balancing weights estimators
by: Yiu, Sean, et al.
Published: (2023)
by: Yiu, Sean, et al.
Published: (2023)
Balancing Weights for Causal Mediation Analysis
by: Kawato, Kentaro
Published: (2025)
by: Kawato, Kentaro
Published: (2025)
Experimental Design For Causal Inference Through An Optimization Lens
by: Zhao, Jinglong
Published: (2024)
by: Zhao, Jinglong
Published: (2024)
DEMO: Dose Exploration, Monitoring, and Optimization Using a Biological Mediator for Clinical Outcomes
by: Yang, Cheng-Han, et al.
Published: (2024)
by: Yang, Cheng-Han, et al.
Published: (2024)
Dempster-Shafer P-values: Thoughts on an Alternative Approach for Multinomial Inference
by: Hoffman, Kentaro, et al.
Published: (2024)
by: Hoffman, Kentaro, et al.
Published: (2024)
Estimands for Early Phase Dose Optimization Trials in Oncology
by: Mukherjee, Ayon, et al.
Published: (2025)
by: Mukherjee, Ayon, et al.
Published: (2025)
TITE-STEIN: Time-to-event Simple Toxicity and Efficacy Interval Design to Accelerate Phase I/II Trials
by: Sun, Hao, et al.
Published: (2025)
by: Sun, Hao, et al.
Published: (2025)
Bridging the Gap Between Design and Analysis: Randomization Inference and Sensitivity Analysis for Matched Observational Studies with Treatment Doses
by: Zhang, Jeffrey, et al.
Published: (2024)
by: Zhang, Jeffrey, et al.
Published: (2024)
Evaluating Bias Reduction Methods in Binary Emax Model for Reliable Dose-Response Estimation
by: Zhang, Jiangshan, et al.
Published: (2025)
by: Zhang, Jiangshan, et al.
Published: (2025)
The Backfill i3+3 Design for Dose-Finding Trials in Oncology
by: Liu, Jiaxin, et al.
Published: (2023)
by: Liu, Jiaxin, et al.
Published: (2023)
GenAI Powered Dynamic Causal Inference with Unstructured Data
by: Nakamura, Kentaro, et al.
Published: (2026)
by: Nakamura, Kentaro, et al.
Published: (2026)
Similar Items
-
ROMI: A Randomized Two-Stage Basket Trial Design to Optimize Doses for Multiple Indications
by: Wang, Shuqi, et al.
Published: (2024) -
BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
by: Chen, Yuxuan, et al.
Published: (2026) -
BOP2-TE: Bayesian Optimal Phase 2 Design for Jointly Monitoring Efficacy and Toxicity with Application to Dose Optimization
by: Chen, Kai, et al.
Published: (2024) -
Dual-criterion Dose Finding Designs Based on Dose-Limiting Toxicity and Tolerability
by: Yang, Yunlong, et al.
Published: (2024) -
Hybrid Non-informative and Informative Prior Model-assisted Designs for Mid-trial Dose Insertion
by: Yamada, Kana, et al.
Published: (2026)